Podraza Zofia, Poplicha Karol, Ufniarski Tomasz, Ucieklak Jarosław, Łysiak Natalia, Mizerska-Wasiak Małgorzata
Science Students' Association at Department of Pediatrics and Nephrology, Medical University of Warsaw, 02-091 Warsaw, Poland.
Department of Pediatrics and Nephrology, Medical University of Warsaw, 02-091 Warsaw, Poland.
J Clin Med. 2025 Apr 29;14(9):3055. doi: 10.3390/jcm14093055.
This study aimed to identify clinical and laboratory predictors of kidney involvement and disease relapse in pediatric patients with IgA vasculitis (Immunoglobulin A vasculitis, IgAV). A retrospective cohort study was conducted on 173 children diagnosed with IgAV at the Children's Clinical Hospital of the Medical University of Warsaw between 2018 and 2022. Patients were categorized into groups based on renal involvement (IgAVN+ vs. IgAVN-) and disease recurrence. The analysis included demographic data, clinical manifestations, allergy history, presence of infection, duration of hospitalization, relapse occurrence, the interval between the first and second hospitalization, and laboratory markers. Renal involvement was observed in 42% of cases, while disease recurrence occurred in 9.25% of patients. IgAVN+ patients were older, had longer hospital stays, and more frequently exhibited gastrointestinal symptoms, consistent with previous research. A history of allergic conditions was more prevalent in both the IgAVN+ and recurrence groups. An increase in IgA levels over time was associated with a higher risk of nephropathic development. Patients with recurrences had higher IgM levels and an elevated neutrophil-to-lymphocyte ratio (NLR) ( = 0.07). In the ROC (Receiver Operating Characteristic) analysis, a cutoff value of 1.67 for NLR (AUC 0.71; = 0.0002; sensitivity 0.87; specificity 0.58) was identified as a risk factor for disease recurrence. Older age at disease onset, gastrointestinal involvement, and allergies are associated with renal involvement in pediatric IgAV. Immune dysregulation, reflected by elevated NLR and IgM, may contribute to disease recurrence. It is important to monitor changes in IgA levels over time, as an increase in IgA concentration is a risk factor for the development of nephropathy. Additionally, calculating the NLR is recommended, as it may indicate the probability of disease recurrence.
本研究旨在确定小儿IgA血管炎(免疫球蛋白A血管炎,IgAV)患者肾脏受累及疾病复发的临床和实验室预测指标。对2018年至2022年期间在华沙医科大学儿童临床医院诊断为IgAV的173名儿童进行了一项回顾性队列研究。根据肾脏受累情况(IgAVN+与IgAVN-)和疾病复发情况将患者分组。分析内容包括人口统计学数据、临床表现、过敏史、感染情况、住院时间、复发情况、首次和第二次住院间隔时间以及实验室指标。42%的病例观察到肾脏受累,而9.25%的患者出现疾病复发。IgAVN+患者年龄较大,住院时间较长,更频繁地出现胃肠道症状,这与先前的研究一致。过敏情况史在IgAVN+组和复发组中更为普遍。随着时间推移IgA水平升高与肾病发展风险较高相关。复发患者的IgM水平较高且中性粒细胞与淋巴细胞比值(NLR)升高(P = 0.07)。在ROC(受试者工作特征)分析中,NLR的截断值为1.67(AUC 0.71;P = 0.0002;敏感性0.87;特异性0.58)被确定为疾病复发的危险因素。疾病发病时年龄较大、胃肠道受累和过敏与小儿IgAV患者的肾脏受累有关。NLR和IgM升高反映的免疫失调可能导致疾病复发。随着时间监测IgA水平变化很重要,因为IgA浓度升高是肾病发展的危险因素。此外,建议计算NLR,因为它可能表明疾病复发的可能性。